iSelect Fund Management

Flywheel.io is a cloud-based data management platform tailored for biomedical research and collaboration. Founded in 2012 and headquartered in Minneapolis, Minnesota, the company provides a suite of tools designed to enhance the workflow of scientists and researchers. Its platform supports medical imaging, scientific computation, and content management, enabling users to capture, manage, and analyze research data efficiently. By utilizing cloud scalability and automation, Flywheel facilitates collaborative research, machine learning applications, and multicenter studies, which help organizations streamline their research processes. The platform, featuring a modern web interface and extensible compute engine, aims to eliminate bottlenecks in innovation, allowing researchers to focus on scientific discovery rather than IT challenges.

Growers Edge is an agricultural fintech company that develops software and analytics for risk and crop management, offering a platform that provides customized solutions to farmers, agencies, and retailer networks, along with cash flow lending for inputs and agricultural technologies and risk management tied to crop management plans. Founded in 2017 and headquartered in Johnston, Iowa, the company uses data analytics to facilitate financing for inputs, deliver insights into market trends and crop performance, and help farmers adopt new technologies to improve profitability and safeguard investments.

Vestaron develops and manufactures peptide-based biologic crop protection products. Its offerings include Spear-T for thrips control in greenhouses, Spear-Lep for fruits and vegetables, and Leprotec for field use. Headquartered in Durham, North Carolina with a research center in Kalamazoo, Michigan, Vestaron aims to provide growers with effective, safe, and sustainable biopesticides.

Vestaron develops and manufactures peptide-based biologic crop protection products. Its offerings include Spear-T for thrips control in greenhouses, Spear-Lep for fruits and vegetables, and Leprotec for field use. Headquartered in Durham, North Carolina with a research center in Kalamazoo, Michigan, Vestaron aims to provide growers with effective, safe, and sustainable biopesticides.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy-based treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and headquartered in Columbia, Missouri, the company has created a proprietary drug product that functions as a minimally invasive autologous cancer vaccine. This treatment involves the intratumoral injection of a carbohydrate polymer following tumor ablation, which harnesses the immune system's response to tumor-associated neoantigens released during the process. By doing so, ImmunoPhotonics aims to generate a systemic anti-tumor immune response, facilitating the treatment of late-stage metastatic cancers. The company has established a strategic partnership with Veterinary Cancer Therapeutics, LLC, enhancing its potential for clinical application.

Flywheel.io is a cloud-based data management platform tailored for biomedical research and collaboration. Founded in 2012 and headquartered in Minneapolis, Minnesota, the company provides a suite of tools designed to enhance the workflow of scientists and researchers. Its platform supports medical imaging, scientific computation, and content management, enabling users to capture, manage, and analyze research data efficiently. By utilizing cloud scalability and automation, Flywheel facilitates collaborative research, machine learning applications, and multicenter studies, which help organizations streamline their research processes. The platform, featuring a modern web interface and extensible compute engine, aims to eliminate bottlenecks in innovation, allowing researchers to focus on scientific discovery rather than IT challenges.

Sentera designs, manufactures, and distributes integrated software and sensor products for various industries. It specializes in drone sensors, video technology services, and OnTop, a mobile app and desktop client for inspection access. Serving agriculture, mining, infrastructure, security, and public safety sectors, Sentera incorporates machine learning and data science tools to gather and analyze data, providing insights to improve outcomes.

Agrible, Inc. is an agriculture technology company based in Champaign, Illinois, established in 2007 by a group of researchers from the University of Illinois. The company specializes in developing software solutions aimed at enhancing operational efficiency for growers across the globe. Its flagship product, Morning Farm Report, provides comprehensive field-level forecasts and data, including yield predictions, nutrient availability, and weather conditions. Additional tools include Find My Seed, which helps users choose seeds based on various criteria, and Pocket Rain Gauge, which offers localized rainfall measurements. Agrible also provides Pocket Spray Smart, an application that informs users about field-specific spraying conditions, and Pocket Drone Control, which assists in crop damage assessments through aerial imagery. The company's innovative and user-friendly products cater to a diverse clientele, including independent growers, major food brands, crop consultants, and agricultural retailers, enabling them to make informed decisions and improve production sustainably.

PopBookings is a cloud-based staffing solution company that specializes in automating the hiring process for temporary and promotional staffing agencies. Founded in 2014 and headquartered in Lenexa, Kansas, PopBookings offers a comprehensive platform designed to simplify the booking and communication with promotional staff. Its features include database management, a custom-branded talent portal, drag-and-drop scheduling, geo check-ins, and an event dashboard with status alerts. By connecting agencies and brands with event workers, PopBookings facilitates the organization of events, helping to celebrate brands through effective staffing solutions.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

Kultevat, Inc. is a biotechnology company focused on the breeding and cultivation of industrially relevant dandelion varieties, specifically the Russian Dandelion, to serve as a sustainable source of natural rubber. Founded in 2013 and based in Portageville, Missouri, the company engages in the processing and extraction of dandelion rubber and related co-products, offering latex and bulk rubber products for various applications, including gloves, medical devices, automotive parts, and biofuels. Kultevat aims to provide an environmentally friendly alternative to synthetic rubber, contributing to reduced ecological impact while serving agricultural markets in the United States, Canada, and Europe. Its innovative approach combines crop improvement and strain selection to enhance the performance and versatility of natural rubber.

Epharmix, Inc. is a digital healthcare company that specializes in developing clinically validated, condition-specific communication tools designed for the healthcare industry. Founded in 2015 and based in St. Louis, Missouri, the company creates digital interventions tailored to various patient populations, aimed at enhancing patient-physician engagement. Epharmix's products facilitate the automatic collection of clinical data over time, which allows for algorithmic alerts to healthcare providers, thereby supporting chronic care management for patients. By focusing on underserved patient groups, Epharmix enables care teams to improve healthcare delivery while reducing workload through proven interventions that enhance both engagement and health outcomes.

StreamLink Software-is a Software-as-a-Service company that develops grant management software for nonprofits and the public sector. Ther grants management solution, AmpliFund, is designed for managing every stage of the grant lifecycle and is at the forefront of automating grant compliance and data standardization in the public sector. It was founded in 2008 and is headquartered in Cleveland, Ohio.

Neuros Medical, Inc. is a neuromodulation company dedicated to developing innovative therapies to address unmet medical needs for patients globally. Founded in 2008 and headquartered in Willoughby Hills, Ohio, the company specializes in its proprietary platform technology known as Electrical Nerve Block. This technology is designed to eliminate chronic pain across various conditions, including neuroma/residual limb pain, chronic post-surgical pain, and chronic migraine. The Neuros Altius System, one of its key products, includes an implantable generator with an integrated rechargeable battery, a cuff electrode, and external devices, further demonstrating the company's commitment to advancing pain management solutions.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

Ward Alternative Energy was born from a passion to provide American, low cost, clean transportation fuels for vehicles. Discovering, producing and compressing natural gas in the field is a deep upstream expertise built over the past 50 years at Ward Petroleum. At Ward Alternative Energy, we add the down-stream natural gas, fueling and NGV expertise of our industry veterans. Our team is well prepared to be the natural gas fuels, station services and vehicle services provider and partner of choice for fleets. We started our business in Colorado in 2012 but are now expanding to Wyoming, New Mexico, northwest Texas and east through Kansas to St. Louis.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy-based treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and headquartered in Columbia, Missouri, the company has created a proprietary drug product that functions as a minimally invasive autologous cancer vaccine. This treatment involves the intratumoral injection of a carbohydrate polymer following tumor ablation, which harnesses the immune system's response to tumor-associated neoantigens released during the process. By doing so, ImmunoPhotonics aims to generate a systemic anti-tumor immune response, facilitating the treatment of late-stage metastatic cancers. The company has established a strategic partnership with Veterinary Cancer Therapeutics, LLC, enhancing its potential for clinical application.

Kultevat, Inc. is a biotechnology company focused on the breeding and cultivation of industrially relevant dandelion varieties, specifically the Russian Dandelion, to serve as a sustainable source of natural rubber. Founded in 2013 and based in Portageville, Missouri, the company engages in the processing and extraction of dandelion rubber and related co-products, offering latex and bulk rubber products for various applications, including gloves, medical devices, automotive parts, and biofuels. Kultevat aims to provide an environmentally friendly alternative to synthetic rubber, contributing to reduced ecological impact while serving agricultural markets in the United States, Canada, and Europe. Its innovative approach combines crop improvement and strain selection to enhance the performance and versatility of natural rubber.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy-based treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and headquartered in Columbia, Missouri, the company has created a proprietary drug product that functions as a minimally invasive autologous cancer vaccine. This treatment involves the intratumoral injection of a carbohydrate polymer following tumor ablation, which harnesses the immune system's response to tumor-associated neoantigens released during the process. By doing so, ImmunoPhotonics aims to generate a systemic anti-tumor immune response, facilitating the treatment of late-stage metastatic cancers. The company has established a strategic partnership with Veterinary Cancer Therapeutics, LLC, enhancing its potential for clinical application.

CrazyForEducation LLC, founded by Dr. Renato Cataldo in 2012 and based in St. Louis, Missouri, specializes in developing online teaching software and educational tools aimed at enhancing the learning experience for schools, teachers, students, and professionals. The company offers a comprehensive platform designed for flip teaching, which includes tools for lesson assignments, student note-taking, course management, and assessment tracking. Additionally, CrazyForEducation provides professional development for educators, featuring recorded webinars and resources tailored for school districts. Its uTutor.me platform allows users to access and replay video lessons from K-12 and college educators, while ClinPharmEd serves clinical pharmacists and pharmacy students with a video-sharing service for educational content. Through its innovative solutions, CrazyForEducation aims to empower educators and facilitate adaptive teaching models that enhance student learning.

adFreeq, LLC is a personalized classified advertisement platform that connects buyers and sellers in real-time. Founded in 2011 and headquartered in Columbia, Missouri, the company offers the adFreeq adPortal, a versatile JavaScript widget or WordPress plug-in designed for publishers, including online newspapers, media companies, and blogs. This platform allows publishers to seamlessly embed classified advertisements into their websites without the need for hardware or software installation. AdFreeq's self-managed, cloud-based service aggregates personalized classified ads from various sources, including social media and local to national publishers, facilitating a comprehensive browsing experience for users. With additional locations in the United States and China, adFreeq aims to streamline the classified ad process while enhancing accessibility for both advertisers and consumers.

adFreeq, LLC is a personalized classified advertisement platform that connects buyers and sellers in real-time. Founded in 2011 and headquartered in Columbia, Missouri, the company offers the adFreeq adPortal, a versatile JavaScript widget or WordPress plug-in designed for publishers, including online newspapers, media companies, and blogs. This platform allows publishers to seamlessly embed classified advertisements into their websites without the need for hardware or software installation. AdFreeq's self-managed, cloud-based service aggregates personalized classified ads from various sources, including social media and local to national publishers, facilitating a comprehensive browsing experience for users. With additional locations in the United States and China, adFreeq aims to streamline the classified ad process while enhancing accessibility for both advertisers and consumers.

Tansna Therapeutics, Inc. is a drug discovery and development company focused on creating innovative oral medications for the treatment of epilepsy and other central nervous system disorders. Established in 2010 and headquartered in St. Louis, Missouri, the company is dedicated to developing novel therapies aimed at improving the lives of patients suffering from debilitating conditions. Its main product in development is an oral anticonvulsant agent designed to effectively reduce seizure frequency in individuals with epilepsy, providing healthcare professionals with enhanced treatment options for their patients.

Tansna Therapeutics, Inc. is a drug discovery and development company focused on creating innovative oral medications for the treatment of epilepsy and other central nervous system disorders. Established in 2010 and headquartered in St. Louis, Missouri, the company is dedicated to developing novel therapies aimed at improving the lives of patients suffering from debilitating conditions. Its main product in development is an oral anticonvulsant agent designed to effectively reduce seizure frequency in individuals with epilepsy, providing healthcare professionals with enhanced treatment options for their patients.